Money
Dr Reddy's, Aurobindo, Cipla: Pharma Stocks To Remain In Focus Today After Trump's New Generic Drugs Tariff Plan
Indian pharmaceutical stocks are expected to remain in focus on Wednesday after US President Donald Trump announced a phased tariff roadmap for imported generic medicines, offering drugmakers a two-year duty-free window
Ni Mohammad Haris12K nabasa

Indian pharmaceutical stocks are expected to remain in focus on Wednesday after US President Donald Trump announced a phased tariff roadmap for imported generic medicines, offering drugmakers a two-year duty-free window before imposing steep import levies.
The announcement comes as part of the US administration’s broader strategy to encourage pharmaceutical companies to shift manufacturing operations to the United States.